Newsroom

Sorted by: Latest

-

Immunome Reports Second Quarter 2026 Financial Results and Provides Business Update

BOTHELL, Wash.--(BUSINESS WIRE)--Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced financial results for the quarter ended June 30, 2026, and provided a business update. “We continue to execute against our strategy of building a diversified targeted oncology company with multiple opportunities to bring needed therapies to patients,” said Clay B. Siegall, Ph.D., President and Chief Executive Of...
-

NetApp Hosts First Quarter of Fiscal Year 2027 Financial Results Webcast

SAN JOSE, Calif.--(BUSINESS WIRE)--After market close on September 2, 2026, NetApp (NASDAQ: NTAP) will announce financial results for the first quarter of fiscal year 2027, which ended July 31, 2026. NetApp executive management will host a conference call Webcast at 2:30 p.m. Pacific Time to discuss these results and provide their perspective on market dynamics. How to Participate The live Webcast call can be accessed at investors.netapp.com. Please allow at least 15 minutes prior to the start...
-

AbCellera Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

VANCOUVER, British Columbia--(BUSINESS WIRE)--AbCellera Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants...
-

Presidio Production Company Announces Second Quarter 2026 Results

FORT WORTH, Texas--(BUSINESS WIRE)--Presidio Production Company (NYSE: FTW) (“Presidio” or the “Company”), today announced recent highlights and results for the second quarter ended June 30, 2026. Recent Highlights Averaged approximately 22.8 MBoe/d of production for the second quarter, comprising approximately 16% oil, 57% natural gas, and 27% NGLs Reported net income attributable to Presidio Production Company of $14.4 million, or $0.34 per Class A share, for the second quarter of 2026 Genera...
-

City Ventures Sells Harbor Pointe in Santa Ana to Century Communities, Extending Long-Standing Partnerships with the City and Public Homebuilder

IRVINE, Calif.--(BUSINESS WIRE)--City Ventures, a leading Southern California infill homebuilder, today announced the sale of Harbor Pointe, a fully entitled and substantially improved 45-townhome community located at 510–520 N. Harbor Boulevard in the City of Santa Ana, to Century Communities of California, LLC. Century Communities will complete construction and deliver the homes, which include five moderate-income, affordable floor plans, to buyers upon completion of construction. Harbor Poin...
-

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)...
-

Hilton Global Associates Named to the 2026 Inc. 5000 List of America’s Fastest-Growing Private Companies

NEW YORK & NAPLES, Fla.--(BUSINESS WIRE)--Hilton Global Associates Inc. (“Hilton Global”), a global investigative due diligence and strategic intelligence firm, today announced that it has been ranked No. 2,124 on the 2026 Inc. 5000, Inc.’s annual list of the fastest-growing private companies in America. Hilton Global has now appeared on the Inc. 5000 in 2024, 2025, and 2026, underscoring the firm’s sustained growth and continued investment in its people, technology, and global investigative ca...
-

NYSE Group Consolidated Short Interest Report

NEW YORK--(BUSINESS WIRE)--NYSE today reported short interest as of the close of business on the settlement date of July 31, 2026. SETTLEMENT DATE EXCHANGE TOTAL CURRENT SHORT INTEREST TOTAL PREVIOUS SHORT INTEREST (Revised) NUMBER of SECURITIES with a SHORT POSITION NUMBER of SECURITIES with a POSITION >= 5,000 SHARES 07/31/2026 NYSE 18,867,531,730 19,333,378,924 2,906 2,605 07/31/2026 NYSE ARCA 2,197,363,131 2,205,402,543 2,679 1,879 07/31/2026 NYSE AMERICAN 1,081,435,415 1,079,142,620 304...
-

AN2 Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business and Scientific Highlights

MENLO PARK, Calif.--(BUSINESS WIRE)--AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics derived from its boron chemistry platform, today reported financial results for the second quarter ended June 30, 2026. “AN2 will have three Phase 2 programs underway by the end of this year, all of which have the potential to address major unmet needs. Our near-term focus is advancing start-up activi...
-

TherapeuticsMD Announces Second Quarter 2026 Financial Results

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the three months ended June 30, 2026. Second Quarter 2026 Financial Results Net Income from Continuing Operations Net income from continuing operations totaled $164 thousand, compared to net income of $545 thousand for the second quarter of 2025. License Revenues from Continuing Operations The Com...